Send Message
801-2, Jindong Mansion, No. 536 Xueshi Road, Yinzhou, Ningbo 315100, P.R.China
Home ProductsOral Medications

Ambroxol Syrup 15mg/5ml, 100ml Oral Medications

Ambroxol Syrup 15mg/5ml, 100ml Oral Medications

  • Ambroxol Syrup 15mg/5ml, 100ml Oral Medications
Ambroxol Syrup 15mg/5ml, 100ml Oral Medications
Product Details:
Place of Origin: China
Brand Name: Newlystar
Certification: GMP
Model Number: 15mg/5ml, 100ml
Payment & Shipping Terms:
Minimum Order Quantity: 50, 000 bottles
Price: Negotiation
Packaging Details: one bottle/box
Delivery Time: 45days
Payment Terms: L/C, T/T
Supply Ability: 50, 000 bottles per day
Contact Now
Detailed Product Description
Product: Ambroxol Syrup Specification: 15mg/5ml, 100ml
Standard: BP, USP Packing: One Bottle/box
High Light:

oral treatment

,

oral preparation

Ambroxol Syrup 15mg/5ml, 100ml Oral Medications

 

Product : Ambroxol Syrup

Specification : 15mg/5ml, 100ml

Standard : BP, USP

Packing : one bottle/box

 

Description :

Ambroxol is a clinically proven systemically active mucolytic agent. When administered orally onset of action occurs after about 30 minutes. The breakdown of acid mucopolysaccharide fibers makes the sputum thinner and less viscous and therefore more easily removed by coughing. Although sputum volume eventually decreases, its viscosity remains low for as long as treatment is maintained.

 

Indications and Usage :

All forms of tracheobronchitis, emphysema with bronchitis pneumoconiosis, chronic inflammatory pulmonary conditions, bronchiectasis, bronchitis with bronchospasm asthma. During acute exacerbations of bronchitis it should be given with the appropriate antibiotic.

 

Mechanism of action :

Ambroxol is a mucolytic agent. Excessive Nitric oxide (NO) is associated with inflammatory and some other disturbances of airways function. NO enhances the activation of soluble guanylate cyclase and cGMP accumulation. Ambroxol has been shown to inhibit the NO-dependent activation of soluble guanylate cyclase. It is also possible that the inhibition of NO-dependent activation of soluble guanylate cyclase can suppress the excessive mucus secretion, therefore it lowers the phlegm viscosity and improves the mucociliary transport of bronchial secretions.

Contact Details
Newlystar (Ningbo) Medtech Co.,Ltd.

Contact Person: Mr. Luke Liu

Tel: 86--57487019333

Fax: 86-574-8701-9298

Send your inquiry directly to us (0 / 3000)

Other Products